1. , Imaging biomarkers in multiple sclerosis. J Magn Reson Imaging 2010; 31:770–88.
2. , , , , , Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34:661–9.
3.van , , , et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50:1282–8.
4. Nuclear induction. Phys Rev 1946; 70:460–74.
5. , Exchange rates by nuclear magnetic multiple resonance. III. Exchange reactions in systems with several nonequivalent sites. J Chem Phys 1964; 40:1189–96.
6. , Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989; 10:135–44.
7. , , Jr. Selective saturation in magnetization transfer experiments Magn Reson Med 1994; 32:517–22.
8. , 3rd, , Magnetization transfer imaging with pulsed off-resonance saturation: variation in contrast with saturation duty cycle. J Magn Reson Imaging 1994; 4:79–82.
9. , , , et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182:483–91.
10.van , , , et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46:747–54.
11. , , , , Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56:407–15.
12. , , , et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. Am J Neuroradiol 1997; 18:895–901.
13. , , , Magnetization transfer imaging in progressive multifocal leukoencephalopathy. Neurology 1997; 48:534–36.
14. , , , , , Decreased magnetisation transfer ratio due to demyelination: a case of central pontine myelinolysis, J Neurol Neurosurg Psychiatry 1996; 61:208–9.
15. , , , et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 1995; 59:487–92.
16. , , The pathological evolution of multiple sclerosis, Neuropathol Appl Neurobiol 1992; 18:319–34.
17. , , , et al. Serial magnetization transfer imaging in acute optic neuritis. Brain 2004; 127:692–700.
18. , , , et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 2000; 55:1506–10.
19. , , , , Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med 2005; 53:1415–22.
20. , , , Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. AJNR Am J Neuroradiol 1996; 17:1539–47.
21. , , , , Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. Am J Neuroradiol 1995; 16:1473–9.
22. , , , , , Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 2000; 54:1139–44.
23. , , Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques. Mult Scler 1999; 5:273–82.
24. , , , et al. Diffuse axonal pathology detected with magnetization transfer imaging following brain injury in the pig. Magn Reson Med 1999; 41:727–33.
25.van , , , , Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36:632–6.
26. , , , et al. Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers. Am J Neuroradiol 2000; 21:133–6.
27. , , Scan-rescan variation of measures derived from brain magnetization transfer ratio histograms obtained in healthy volunteers by use of a semi-interleaved magnetization transfer sequence Am J Neuroradiol 2001; 22:681–4.
28. , , Au , et al. Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 2004; 20:765–71.
29. , , , et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am J Neuroradiol 2005; 26:119–27.
30. , , , , , MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosurg Psychiatry 1998; 64:197–203.
31. , , , , , A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346:158–64.
32. , , , et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40:229–35.
33. , , , et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 1998; 121:2011–20.
34. , , , et al. Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast. Am J Neuroradiol 1998; 19:1863–7.
35. , , , et al. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis J Neurol 2001; 248:215–24.
36. , , , , , Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998; 51:758–64.
37. , , , , Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. Am J Neuroradiol 1996; 17:1041–9.
38. , , , et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. Am J Neuroradiol 1998; 19:675–83.
39. , , Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement. J Neurol Sci 1998; 159:162–5.
40. , , , et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 1998; 50:1289–93.
41. , , , , Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43:809–14.
42. , , , et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998; 51:1689–97.
43. , , , et al. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997; 244:308–11.
44. , , , Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 1998; 51:1150–5.
45. , , , , Long-term changes of magnetization transfer-derived measures from patients with relapsing–remitting and secondary progressive multiple sclerosis. Am J Neuroradiol 1999; 20:821–7.
46. , , , , Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging. Magn Reson Imaging 1999; 17:979–84.
47. , , , , Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008; 63:254–62.
48. , , Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994; 36 Suppl:S42–6.
49. , , , Activity revealed in MRI of multiple sclerosis without contrast agent. A preliminary report. Magn Reson Imaging 2000; 18:139–42.
50. , , , et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999; 353:964–9.
51. , , , et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis, Neurology 1995; 45:478–82.
52. , , , , , Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995; 196:511–515.
53. , , , et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36:62–7.
54. , , Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. Am J Neuroradiol 2001; 22:1893–900.
55. , , , , Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. Am J Neuroradiol 1995; 16:253–8.
56. , , , et al. Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study. J Neurol Neurosurg Psychiatry 2000; 68:170–7.
57. , , Magnetization transfer MR imaging in CNS tuberculosis. Am J Neuroradiol 1999; 20:867–75.
58. , , , , , Characterization of white matter lesions in multiple sclerosis and traumatic brain injury as revealed by magnetization transfer contour plots. Am J Neuroradiol 1999; 20:977–81.
59. , , , , A magnetization transfer imaging study of the brain in patients with migraine. Neurology 2000; 54:507–9.
60. , , , et al. Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. Am J Neuroradiol 1999; 20:839–44.
61. , , , , , Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. Am J Neuroradiol 1997; 18:1541–7.
62. , , , et al. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, Stroke 2001; 32:643–8.
63. , , , et al. Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001; 70:444–9.
64. , , , , , Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2002; 23:267–272.
65. , , , , , Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 2005; 11:135–9.
66.van , , , et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 1997; 15:155–62.
67. , , , , Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. Am J Neuroradiol 2003; 24:1935–40.
68. , , , et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50:1601–08.
69. , , , et al. MR outcome parameters in multiple sclerosis: comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note). Am J Neuroradiol 1998; 19:1857–62.
70. , , , A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: correlations with changes of T2 and magnetization transfer lesion loads, J Neurol Sci 1998; 158:203–8.
71. , , , et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997; 244:266–70.
72. , , , , Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. Am J Neuroradiol 2001; 22:1462–7.
73. , , , et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68:157–61.
74. , , , et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001; 124:2540–9.
75. , , , et al. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 2000; 55:940–6.
76. , , , , , Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. Am J Neuroradiol 2000; 21:1034–8.
77. , , , et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999; 52:588–94.
78. , , , , , A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol 2002; 249:535–7.
79. , , , , , Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129:2620–7.
80. , , , , , Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 2002; 51:330–9.
81. , Cortical reorganisation in patients with MS. J Neurol Neurosurg Psychiatry 2004; 75:1087–9.
82. , Functional MR imaging in multiple sclerosis. Neuroimaging Clin N Am 2009; 19:59–70.
83. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977; 33:15–20.
84. , A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979; 41:81–91.
85. , , , Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. Eur Neurol 1973; 9:1–20.
86. , , , , Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001; 57:1248–52.
87. , The value of new magnetic resonance techniques in multiple sclerosis. Curr Opin Neurol 2000; 13:249–54.
88. , , , , Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler 2002; 8:479–84.
89. , , , et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability, Arch Neurol 2002; 59:1565–71.
90. , , , et al. Magnetization transfer imaging of patients with definite MS and negative conventional MRI. Neurology 1999; 52:845–8.
91. , , , et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000; 54:186–93.
92. , , , et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler 2003; 9:566–73.
93. , , , et al. A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. Arch Neurol 2004; 61:366–8.
94. , , , et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage 2002; 15:537–46.
95. , , , , Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70:311–17.
96. , , , , , Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 2002; 26:62–8.
97. , , , et al. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 2003; 250:67–74.
98. , , de , et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 2002; 249:662–8.
99. , , , et al. Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging Am J Neuroradiol 2003; 24:495–500.
100. , , , et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 1999; 53:1705–10.
101. , , , , , MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. Am J Neuroradiol 2006; 27:892–4.
102. , The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25:315–20.
103. , , , , , Cortical lesions in multiple sclerosis, Brain 1999; 122 (1):17–26.
104. , , , , Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50:389–400.
105. , , , , , Magnetization transfer ratio histogram analysis of gray matter in relapsing–remitting multiple sclerosis. Am J Neuroradiol 2001; 22:470–5.
106. , , , et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005; 128:2911–25.
107. , , , et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006; 77:40–5.
108. , , , et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006; 129:2008–16.
109. , , , , , Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing–remitting multiple sclerosis. Arch Neurol 2006; 63:736–40.
110. , , , et al. Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. J Neurol 2009; 256:427–435.
111. , , , et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis, Neurology 2008; 71:632–8.
112. , , , , , Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 2002; 194:71–4.
113. , , , et al. Emergence of thalamic magnetization transfer ratio abnormality in early relapsing–remitting multiple sclerosis. Mult Scler 2005; 11:276–81.
114. , , , , , Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch Neurol 2008; 65:1454–9.
115. , , , , , Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. Brain 2006; 129:1031–9.
116. , , , , , Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007; 37:253–61.
117. , , , et al. Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 2004; 62:476–8.
118. , , , , , Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis. Magn Reson Med 2001; 46:600–9.
119. , , , et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy. J Neurol Sci 2001; 184:155–62.
120. , , , et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003; 126:2323–32.
121. , , , et al. Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study. Mult Scler 2002; 8: 52–8.
122.van , , , et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998; 50:1609–17.
123. , , , , , Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms. J Neurol Sci 1999; 171:121–9.
124. , , , et al. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. J Neurol Sci 1999; 171:135–44.
125. , , , , , Magnetization-transfer histogram analysis of the cervical cord in patients with multiple sclerosis. Am J Neuroradiol 1999; 20:1803–8.
126. , , , , Cervical spinal cord MTR histogram analysis in multiple sclerosis using a 3D acquisition and a B-spline active surface segmentation technique. Magn Reson Imaging 2004; 22:891–5.
127. , , , , Optic neuritis: imaging with magnetization transfer. AJR Am J Roentgenol 1997; 169:1709–12.
128. , , , et al. High-resolution anatomic, diffusion tensor, and magnetization transfer magnetic resonance imaging of the optic chiasm at 3T. J Magn Reson Imaging 2005; 22:302–306.
129. , , , et al. Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis. Neuroradiology 1997; 39:441–445.
130. , , , et al. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability. J Neuroimaging 2000; 10:67–72.
131. , , , et al. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS. Neurology 2000; 54:207–13.
132. , , , et al. An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS. Neurology 2004; 63:584–5.
133. , , , et al. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain 2009; 132:1200–9.
134. , , , et al. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry 2000; 69:723–7.
135. , , , , , A magnetic resonance imaging study of the cervical cord of patients with CADASIL. Neurology 2001; 56:1392–4.
136. , , , et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 2002; 59:250–5.
137. , , , et al. A longitudinal conventional and magnetization transfer magnetic resonance imaging study of optic neuritis. Mult Scler 2007; 13:265–8.
138. , , , Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009; 5:256–66.
139. , , , et al. Assessment and correction of B1-induced errors in magnetization transfer ratio measurements. Magn Reson Med 2005; 53:134–40.
140. , , , , Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group. J Magn Reson Imaging 2002; 15:499–504.
141. , , , , , Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J Magn Reson Imaging 2003; 17:389–97.
142. , , , , A simple correction for B1 field errors in magnetization transfer ratio measurements, Magn Reson Imaging 2006; 24:255–263.
143. , , , , , Serial whole-brain magnetization transfer imaging in patients with relapsing–remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. Am J Neuroradiol 1998; 19:1705–13.
144. , , , , , Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001; 7:49–58.
145. , , , , , Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a. Neurology 2000; 54:1741–5.
146. , , , , , Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications. Mult Scler 2005; 11:140–5.
147. , , , et al. The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003; 60:853–60.
148. , , , et al. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis. Arch Neurol 2004; 61:1409–12.
149. , , , et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008; 255:683–91.
150. , , , et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis Mult Scler 2008; 14:455–64.
151. , , , et al. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study, Mult Scler 2010; 16:325–31.
152. , , , et al. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis, Mult Scler 2010; 16:660–9.
153. , , , et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. Neuroimage 2007; 36:1152–8.
154. , , , et al. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels. Arch Neurol 2009; 66:375–81.
155. , De , , et al. Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 2001; 56:1331–4.